Breast cancer is a complex condition that develops when abnormal cells in breast tissue grow uncontrollably. Rather than being a single disease, it encompasses a diverse group of conditions that differ according to where the cancer begins, whether it spreads into surrounding tissue, and the biological features of the cancer cells. Understanding the types of breast cancer helps doctors select appropriate, targeted treatment options.
This guide explores the main types of breast cancer, explains how specialists distinguish them, and helps ensure that you or your loved ones get the care that is deserved.
Why Are There Different Types of Breast Cancer?
The human breast is composed of specialized structures, including milk-carrying ducts, milk-producing lobules, and supportive connective and vascular tissues. Most breast cancers are carcinomas, which begin in the epithelial cells lining organs and tissues.
Breast cancer classification systems generally look at three core questions:
- Where the cancer starts: Whether abnormal growth originates in the ducts or lobules.
- Whether it has invaded nearby tissue: Whether the cells remain contained or grow into surrounding structures.
- Which biomarkers it carries: The presence or absence of specific hormone receptors and proteins.
Invasive vs. Non-Invasive Breast Cancer
What Is Non-Invasive Breast Cancer?
Non-invasive breast cancer—often referred to as in situ or carcinoma in situ—describes abnormal cells that remain entirely within the original structure. This can occur in a milk duct, without invading deeper layers of breast tissue.
What Is Invasive Breast Cancer?
Invasive breast cancer occurs when malignant cells break through the lining of the ducts or lobules and grow into surrounding breast tissue.
What Are the Most Common Types of Breast Cancer?
1. Invasive Ductal Carcinoma (IDC)
Invasive ductal carcinoma begins in the milk ducts and spreads into surrounding breast tissue. According to the American Cancer Society, IDC is by far the most common type of invasive breast cancer, representing approximately 80% of all diagnoses. IDC cells can travel through the lymphatic system to underarm (axillary) lymph nodes. In clinical pathology, it is frequently described as invasive breast carcinoma of no special type (NST).
The primary symptom of Invasive Ductal Carcinoma breast cancer is a new, hard, painless lump with uneven borders. Additional symptoms include skin dimpling, nipple inversion, nipple discharge, or visible changes in breast shape.
2. Invasive Lobular Carcinoma (ILC)
Invasive lobular carcinoma starts in the milk-producing lobules and invades nearby tissue. Unlike IDC, ILC cells tend to grow in dispersed, single-file patterns rather than forming a distinct, firm lump. This growth pattern can make ILC harder to detect on standard mammograms, as it often presents as a subtle area of thickening. ILC represents about 10% to 15% of all invasive breast cancers.
ILC rarely forms a distinct, firm lump because it grows in single-file cellular lines. Instead, Invasive lobular carcinoma breast cancer typically causes an area of fullness, swelling, or skin thickening in the breast.
3. Ductal Carcinoma in Situ (DCIS)
Ductal carcinoma in situ is an early, non-invasive form of breast cancer, often referred to as stage 0. DCIS involves abnormal cells that remain confined inside the milk ducts. True DCIS cannot spread to lymph nodes or distant organs because the abnormal cells have not broken through the duct wall, making it non-invasive.
Most people with DCIS experience zero visible symptoms. On rare occasions, it causes a small breast lump or bloody nipple discharge. DCIS is frequently detected during routine screening mammography. While some cases can eventually progress to invasive cancer, progression is not inevitable.
Types of Breast Cancer Based on Hormone Receptors and HER2
Pathologists test every breast cancer sample for cellular markers that act as growth engines. These biomarker categories determine systemic drug choices.
| Subtype | Estrogen Receptor (ER) | Progesterone Receptor (PR) | HER2 Status | Primary Clinical Relevance |
| Hormone Receptor-Positive | Positive | Positive or Negative | Negative | Responds well to hormone-blocking therapies. |
| HER2-Positive | Varies | Varies | Positive | Treated with targeted HER2 therapies. |
| Triple-Negative (TNBC) | Negative | Negative | Negative | Aggressive behavior; treated via chemotherapy and immunotherapy. |
| Triple-Positive | Positive | Positive | Positive | Requires combined hormone, targeted, and standard therapies. |
1. Hormone Receptor-Positive Breast Cancer
Some breast cancers rely on hormones to fuel their growth. These cells test positive for estrogen receptors (ER), progesterone receptors (PR), or both. Knowing this status allows oncologists to recommend hormone therapy to block these growth signals. Hormone Receptor-Positive Breast Cancer recurrence in late-stage disease and spread typically involves the bones, liver, or lungs.
2. HER2-Positive Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is a protein that regulates cell growth. In HER2-positive breast cancers, the cells produce excess HER2 protein or exhibit increased gene activity, driving rapid growth. These cancers can often be treated effectively with specialized HER2-targeted medicines.
3. Triple-Negative Breast Cancer (TNBC)
Triple-negative breast cancer tests negative for estrogen receptors, progesterone receptors, and HER2 proteins. Because it lacks these three targets, hormone therapies and HER2-targeted drugs are ineffective.
TNBC has a higher tendency to spread within the first few years, commonly traveling to the lungs, liver, and brain. Individuals notice a fast-growing, distinct breast mass or swelling in underarm lymph nodes. Treatment for triple-negative breast cancer typically relies on a combination of surgery, radiation, and chemotherapy.
4. Triple-Positive Breast Cancer
Triple-positive breast cancer describes a tumor that tests positive for estrogen receptors, progesterone receptors, and HER2 proteins simultaneously. Metastases can affect bones, viscera (liver, lungs), and the brain. Patients with triple-positive breast cancer benefit from a combination of multiple biomarker features to guide comprehensive treatments.
Other Important Types of Breast Cancer
1. Inflammatory Breast Cancer (IBC)
Inflammatory breast cancer is an aggressive, rare form of invasive breast cancer where cancer cells block lymph vessels in the skin. This blockage causes rapid skin changes, including redness, warmth, swelling, and a pitted texture resembling an orange peel (peau d’orange). It rarely forms a distinct lump. IBC accounts for 1% to 5% of all breast cancer cases.
2. Paget Disease of the Breast
Paget disease of the breast is an uncommon condition where cancer cells collect in and around the nipple and areola. It accounts for 1% to 3% of all breast cancers. Symptoms of Paget disease of the breast include persistent scaling, redness, crusting, or discharge, frequently accompanied by an underlying ductal carcinoma. It is frequently mistaken for eczema.
3. Metastatic Breast Cancer
Metastatic, or stage IV, breast cancer occurs when the disease has spread from the breast to distant body sites, such as the bones, liver, lungs, or brain. Metastasis describes the physical extent of the spread rather than a distinct cell-of-origin category.
Symptoms of Metastatic breast cancer depend on where the cancer spreads, such as bone pain, persistent cough, shortness of breath, jaundice, abdominal swelling, or frequent headaches and dizziness.
4. Recurrent Breast Cancer
Recurrent breast cancer refers to disease that returns months or years after initial successful treatment. The breast cancer can recur locally in the same breast, regionally in nearby lymph nodes, or distantly in other organs.
Rare Types of Breast Cancer
- Mucinous carcinoma: A rare type of breast cancer where cancer cells float within pools of mucus.
- Tubular carcinoma: A slow-growing, highly treatable invasive cancer shaped like small microscopic tubes.
- Medullary-pattern carcinoma: A soft, fleshy tumor with distinct microscopic borders and significant white blood cell activity.
- Metaplastic carcinoma: A rare, complex group of breast cancers where cells transform into completely different cell types, such as squamous or spindle cells.
- Micropapillary and cribriform carcinomas: Uncommon variants recognized by unique microscopic growth arrangements. Micropapillary grows in ring-like clusters with higher lymph node spread, while cribriform forms nest-like patterns with low spread risk.
- Breast angiosarcoma: A rare malignancy originating in the cells lining blood or lymph vessels.
- Phyllodes tumors: Rare tumors originating in connective breast tissue; while the vast majority are benign, roughly 25% are cancerous.
Types of Breast Cancer in Men
Although male breast cancer is rare, accounting for less than 1% of all breast cancer diagnoses, men can develop the disease because they possess small amounts of breast tissue behind the nipple. Invasive ductal carcinoma is the most frequent diagnosis in men. Male breast cancer shares similar biological classifications with female breast cancer, and symptoms such as a painless lump, nipple retraction, or skin changes warrant immediate medical evaluation.]
Mastectomy is the primary choice for the treatment of invasive ductal carcinoma in men, due to limited male breast tissue, often followed by hormone therapy (tamoxifen) since most male breast cancers are hormone receptor-positive.
How Do Doctors Identify the Type of Breast Cancer?
Breast cancer classification and diagnosis involve a multidisciplinary approach:
- Imaging: Mammograms, ultrasounds, and MRIs help locate and visualize suspicious tissue abnormalities.
- Biopsy: A tissue sample is extracted and analyzed under a microscope to confirm a diagnosis.
- Pathology and Biomarker Testing: Laboratory analysis establishes the tumor grade (how abnormal cells look) and biomarker status (ER, PR, and HER2).
How Does Breast Cancer Type Affect Treatment?
Treatment plans are personalized based on the precise types of breast cancer, stage, grade, biomarker profile, and individual health factors.
Healthcare teams rely on diverse medical tools to clear cancer and minimize the risk of return:
- Surgery: Removes local tumors via lumpectomy or mastectomy.
- Radiation Therapy: High-energy rays eliminate microscopic cells remaining in the chest wall or lymph nodes.
- Chemotherapy: Systemic medications destroy rapidly dividing cancer cells across the entire body.
- Hormone Therapy: Blocks natural hormone signals in hormone receptor-positive cancers.
- HER2-Targeted Therapy: Specifically targets and neutralizes overexpressed HER2 proteins.
- Immunotherapy: Helps the body’s natural immune system locate and destroy cancer cells.
Bottom Line
Learning about the types of breast cancer can make an unfamiliar diagnosis easier to understand, but no single label tells the whole story. Each person’s diagnosis requires individual assessment, and treatment decisions depend on several clinical factors.
If you or someone you care about receives a breast cancer diagnosis, ask the healthcare team to explain the pathology report, clarify unfamiliar terms, and discuss the available treatment options.
For anyone noticing an unusual breast change, visiting the hospital and seeking medical advice rather than trying to identify the cause alone is an important step. Reliable information and open conversations with qualified healthcare professionals can help people approach the next steps with greater confidence.
